Single-chain antibody-mediated gene delivery into ErbB2-positive human breast cancer cells.
about
Identification of MCAM/CD146 as the target antigen of a human monoclonal antibody that recognizes both epithelioid and sarcomatoid types of mesotheliomaLipopolyplex for Therapeutic Gene Delivery and Its Application for the Treatment of Parkinson's DiseaseNanomedicines based on recombinant fusion proteins for targeting therapeutic siRNA oligonucleotides.Suicide HSVtk gene delivery by neurotensin-polyplex nanoparticles via the bloodstream and GCV Treatment specifically inhibit the growth of human MDA-MB-231 triple negative breast cancer tumors xenografted in athymic mice.Epithelial membrane protein-2 is a novel therapeutic target in ovarian cancer.The role of HER2 in cancer therapy and targeted drug deliveryEpidermal growth factor targeting of bacteriophage to the choroid plexus for gene delivery to the central nervous system via cerebrospinal fluid.In vitro and in vivo evaluation of ⁶⁴Cu-radiolabeled KCCYSL peptides for targeting epidermal growth factor receptor-2 in breast carcinomas.Design and characterization of novel recombinant listeriolysin O-protamine fusion proteins for enhanced gene delivery.High-level expression, purification, and characterization of bifunctional ScFv-9R fusion protein.scFv antibody: principles and clinical applicationDevelopment of an MRI-visible nonviral vector for siRNA delivery targeting gastric cancer.Molecular design and delivery of siRNA.Gene delivery to vascular endothelium using chemical vectors: implications for cardiovascular gene therapy.Applying horizontal gene transfer phenomena to enhance non-viral gene therapyAn update on RNA interference-mediated gene silencing in cancer therapy.Single-chain antibody-delivered Livin siRNA inhibits human malignant melanoma growth in vitro and in vivo.ScFv-decorated PEG-PLA-based nanoparticles for enhanced siRNA delivery to Her2⁺ breast cancer.Targeted delivery of PLK1-siRNA by ScFv suppresses Her2+ breast cancer growth and metastasis.Engineering of Escherichia coli for targeted delivery of transgenes to HER2/neu-positive tumor cells.Comparison between the interactions of adenovirus-derived peptides with plasmid DNA and their role in gene delivery mediated by liposome-peptide-DNA virus-like nanoparticles.RNAi therapy: antibodies guide the way.Decomposing Dynamical Couplings in Mutated scFv Antibody Fragments into Stabilizing and Destabilizing Effects.Receptor-targeted siRNAs.A novel therapeutic drug for colon cancer: EpCAM scFv-truncated protamine (tp)-siRNA.Anti-HER2 scFv-Directed Extracellular Vesicle-Mediated mRNA-Based Gene Delivery Inhibits Growth of HER2-Positive Human Breast Tumor Xenografts by Prodrug Activation.ScFvs as Allosteric Inhibitors of VEGFR-2: Novel Tools to Harness VEGF Signaling.
P2860
Q24646373-E9BC0E99-9A5C-499A-AFC5-3C14350C814FQ26752578-1FD57DAF-F911-4D43-AA97-7F0E7C747AA2Q27692125-9DD8AEAE-2583-4EB2-A8C7-A7450AB59BCCQ33604560-781CE7BF-CA9C-4D51-834D-9ACFA0981019Q34033964-3743EC7B-49D3-432A-9753-41D457F89E35Q34054213-EC9D1BFB-18B3-4D64-87AC-9E55FBA8F2BDQ34203693-09708156-4AC0-4CFE-BD8C-FE4FE073AD25Q34519479-49017169-B492-4B70-8CF7-FA66B6CFFA6BQ35057551-B4C7465E-9565-43E2-91E0-C9233F713F11Q35092448-0C3383AD-4F3E-4020-84CF-49F682CADE8AQ35852647-351D5787-B3B2-4BF1-A933-B39785FB0CCBQ36119526-59A19AF8-0CB2-4299-B0FE-D7A68CEEF9A5Q36633638-1E00326A-A6DB-4012-974B-7D0B8B68F7C4Q36810273-6B468B0B-2262-4AF5-AEDE-76FA32D6AE22Q38133156-04E22DBC-1DDF-4B57-817A-D947AC96E5B5Q38227931-AE1EF743-4866-4F84-B80E-3DA3A2CC411FQ38705406-0428B33E-B996-4C99-A889-A8BB2A24E7FBQ38982783-A9795BCD-C1FF-4888-9A64-E421C12E0403Q39361870-8EED10E4-775A-4760-AA14-D7A609F2B509Q39588838-AAE0C5EA-8383-4099-8B0D-E9CBC8D1A16CQ44573717-F9836C90-EA80-4FFE-B929-696DC78BDC9FQ45865381-AD39A950-C493-4E44-AF0E-C01ACEAF7342Q47400764-CE405367-8640-471A-9C37-ADCBE9D8665AQ47616266-9755914A-C018-43BC-9C75-4A18538B1D00Q51075189-34680584-FCAE-4608-801D-1F26BA2C150DQ52684454-B53086C8-477A-4E66-8176-FF0967B03AA4Q54112592-36BFF986-505B-4F25-8AEA-0784CBB59610
P2860
Single-chain antibody-mediated gene delivery into ErbB2-positive human breast cancer cells.
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Single-chain antibody-mediated ...... ive human breast cancer cells.
@ast
Single-chain antibody-mediated ...... ive human breast cancer cells.
@en
type
label
Single-chain antibody-mediated ...... ive human breast cancer cells.
@ast
Single-chain antibody-mediated ...... ive human breast cancer cells.
@en
prefLabel
Single-chain antibody-mediated ...... ive human breast cancer cells.
@ast
Single-chain antibody-mediated ...... ive human breast cancer cells.
@en
P2093
P356
P1433
P1476
Single-chain antibody-mediated ...... ive human breast cancer cells.
@en
P2093
P2888
P304
P356
10.1038/SJ.CGT.7700337
P577
2001-08-01T00:00:00Z
P5875
P6179
1015403065